Document Detail


Hydrazinopropionic acid: a new inhibitor of aminobutyrate transaminase and glutamate decarboxylase.
MedLine Citation:
PMID:  18561486     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This paper deals with the synthesis of 3-pyrazolidone and the biochemical action of hydrazinopropionic acid. The latter compound is formed upon alkaline hydrolysis of 3-pyrazolidone. Hydrazinopropionic acid was found in vitro to be a very potent inhibitor of bacterial aminobutyrate transaminase as well as of aminobutyrate transaminase and glutamate decarboxylase from mouse brain. This inhibition was shown to occur despite the presence of high concentrations of pyridoxal phosphate in the incubation media. Injections of 20 mg hydrazinopropionic acid/kg into mice resulted in complete inhibition of aminobutyrate transaminase in brain and approximately 20 per cent inactivation of glutamate decarboxylase. This inhibition could not be prevented or antagonized by administration of pyridoxine to the animals. Addition of pyridoxal phosphate to homogenates of brain from animals treated with hydrazinopropionic acid also failed to reactivate the enzymes. The tentative conclusion reached from these results is that hydrazinopropionic acid has inhibitory action because of its close similarity to GABA with respect to molecular size, structural configuration and molecular charge distribution. This can be demonstrated by comparing a Dreiding model of hydrazinopropionic acid with that representing GABA.
Authors:
N M van Gelder
Related Documents :
1407006 - Effects of taurine, homotaurine and gaba on hypothalamic and striatal dopamine metabolism.
10761496 - Physostigmine in the treatment of gamma-hydroxybutyric acid overdose.
6258106 - Treatment of huntington disease with gamma-acetylenic gaba an irreversible inhibitor of...
17221946 - Piperazimycins: cytotoxic hexadepsipeptides from a marine-derived bacterium of the genu...
15643586 - Soft tissue augmentation using restylane.
4706916 - A comparative study of the major glycoprotein isolated from normal and neoplastic gastr...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of neurochemistry     Volume:  15     ISSN:  0022-3042     ISO Abbreviation:  J. Neurochem.     Publication Date:  1968 Aug 
Date Detail:
Created Date:  2008-06-19     Completed Date:  2008-08-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985190R     Medline TA:  J Neurochem     Country:  England    
Other Details:
Languages:  eng     Pagination:  747-57     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
4-Aminobutyrate Transaminase / metabolism*
Animals
Brain / cytology,  drug effects,  metabolism*
Dose-Response Relationship, Drug
Enzyme Inhibitors / pharmacology*
Glutamate Decarboxylase / metabolism*
Glycine / analogs & derivatives*,  analysis,  pharmacology
Mice
Pyridoxine / pharmacology
Time Factors
Vitamin B Complex / pharmacology
gamma-Aminobutyric Acid / metabolism,  pharmacology
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 12001-76-2/Vitamin B Complex; 14150-64-2/hydrazinoacetic acid; 56-12-2/gamma-Aminobutyric Acid; 56-40-6/Glycine; 65-23-6/Pyridoxine; EC 2.6.1.19/4-Aminobutyrate Transaminase; EC 4.1.1.15/Glutamate Decarboxylase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An autoradiographic study of the flow of protein and RNA along peripheral nerve.
Next Document:  Developmental changes of choline acetyltransferase (ChAc) activity in chick embryo spinal and sympat...